跳至主要内容
临床试验/EUCTR2005-006136-29-AT
EUCTR2005-006136-29-AT进行中(未招募)1 期

Mikroperfusions-Pilotstudie zur Korrelation von Schmerzreaktion und neurogener Entzündung bei photodynamischer Therapie superfizieller Basaliome(English: Microperfusion-pilotstudy to correlate pain and neurogenic inflammation induced by photodynamic therapy of superficial basal cell carcinomas)

Peter Wolf MD, Department of Dermatology, Medical University of Graz0 个研究点目标入组 15 人开始时间: 2006年7月11日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1)age > 18 years
  • 2)patients with superficial basal cell carcinomas on trunk or extremities
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1)severe general diseases or metastatic tumors
  • 2)systemic immunosuppressive therapy
  • 3)photosensitive skin diseases such as porphyria, Xeroderma pigmentosum or other diseases with defective repair mechanism DNA-repair
  • 4)Autoimmundermatoses (Lupus erythemathodes, Dermatomyositis)
  • 5)Antinuclear antibodies (ds-DNA, Ro/SSA und La/SSB)
  • 6)Known allergy to drugs used in the study (Metvix®, Capsaicin 0,05%-Creme, Diprosicc)
  • 7)pregnancy or lactation
  • 8)coagulopathy or treatment with anticoagulant therapy (e.g. treatment with Marcoumar® oder Sintrom®)
  • 9)Pigmented or sklerodermiform variant of basal cell carcinomas
  • 10)Location of the basalioma in the face

研究者

发起方
Peter Wolf MD, Department of Dermatology, Medical University of Graz

相似试验